Skip to main content
Sunday
December 28, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
SUNDAY,
DECEMBER 28, 2025
Oxford-AstraZeneca vaccine
Oxford-AstraZeneca vaccine
Bangladesh gets over 8m AstraZeneca jabs from Japan, UK
The government has so far achieved 32% of the overall vaccination target
US to share up to 60 mln AstraZeneca vaccine doses globally
Australia to continue AstraZeneca vaccine rollout, review EU findings
Questions about AstraZeneca jab linger
Covax expects full vaccine supplies from India's Serum in May, says Unicef
Missteps could mar long-term credibility of AstraZeneca shot
AstraZeneca may have provided incomplete efficacy data from latest Covid-19 trial: NIAID
AstraZeneca vaccine 79% effective in US trial
How worried should we be about reports of blood clots and AstraZeneca's vaccine?
Health experts pore over AstraZeneca safety data as Europe reels from vaccine suspensions
Netherlands halts use of AstraZeneca Covid-19 vaccine
Spanish regions halt AstraZeneca shots over blood clot concerns
No clotting case in India after Oxford dose
Show More